Hint mode is switched on Switch off

Aurisco Pharmaceutical Co, ordinary share
605116, CNE1000042S4

Add a stock to WL
Choose all Reset all
Aurisco Pharmaceutical Co, сountry — China
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Dividends

Issuer

Profile
Aurisco Pharmaceutical Co., Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. ...
Aurisco Pharmaceutical Co., Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. It also provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Aurisco Pharmaceutical Co Ltd
  • Industry
    Pharmaceutical Preparation and Biotechnology

Related Stock indices

Indicators

News

05/11/2025 “Aurisco Pharmaceutical Co., Ltd.”Announcement on Progress in Repurchasing Shares through Call Auction
05/11/2025 “Aurisco Pharmaceutical Co., Ltd.”Announcement on Shareholding Reduction Plan for Shareholders
28/01/2025 Aurisco Pharmaceutical Chairman Proposes Share Repurchase Plan
29/07/2024 Aurisco Pharmaceutical Co., Ltd.: Announcement on Online Lot-winning Rate and Priority Allotment Results of Public Issuance of Convertible Corporate Bonds to Non-specific Objects
All organization news

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.